The Clorox Company $CLX Shares Sold by Lion Street Advisors LLC

Lion Street Advisors LLC cut its stake in shares of The Clorox Company (NYSE:CLX) by 2.8% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 5,125 shares of the company’s stock after selling 147 shares during the quarter. Lion Street Advisors LLC’s holdings in Clorox were worth $615,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. MGO One Seven LLC grew its stake in shares of Clorox by 7.1% during the 2nd quarter. MGO One Seven LLC now owns 3,218 shares of the company’s stock worth $386,000 after purchasing an additional 212 shares during the period. SPC Financial Inc. boosted its position in shares of Clorox by 18.3% in the 2nd quarter. SPC Financial Inc. now owns 4,745 shares of the company’s stock worth $570,000 after buying an additional 735 shares in the last quarter. CWM LLC boosted its position in shares of Clorox by 21.1% in the 2nd quarter. CWM LLC now owns 43,843 shares of the company’s stock worth $5,264,000 after buying an additional 7,649 shares in the last quarter. Vanguard Personalized Indexing Management LLC boosted its position in shares of Clorox by 12.0% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 15,667 shares of the company’s stock worth $1,882,000 after buying an additional 1,676 shares in the last quarter. Finally, Concurrent Investment Advisors LLC boosted its position in shares of Clorox by 1.2% in the 2nd quarter. Concurrent Investment Advisors LLC now owns 20,108 shares of the company’s stock worth $2,414,000 after buying an additional 232 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

CLX has been the topic of several recent research reports. UBS Group decreased their price objective on shares of Clorox from $134.00 to $128.00 and set a “neutral” rating on the stock in a research report on Wednesday. Barclays decreased their price objective on shares of Clorox from $118.00 to $112.00 and set an “underweight” rating on the stock in a research report on Tuesday, September 30th. Morgan Stanley decreased their price objective on shares of Clorox from $150.00 to $137.00 and set an “equal weight” rating on the stock in a research report on Friday, August 1st. Jefferies Financial Group decreased their price objective on shares of Clorox from $167.00 to $145.00 and set a “buy” rating on the stock in a research report on Thursday, June 26th. Finally, Bank of America decreased their price objective on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 8th. One analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Reduce” and a consensus price target of $131.92.

Insider Transactions at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. This represents a 21.72% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 0.57% of the company’s stock.

Clorox Price Performance

NYSE:CLX opened at $120.14 on Monday. The firm has a market cap of $14.63 billion, a price-to-earnings ratio of 18.43, a price-to-earnings-growth ratio of 0.98 and a beta of 0.52. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The company’s 50-day moving average is $122.21 and its two-hundred day moving average is $128.57. The Clorox Company has a 12-month low of $116.53 and a 12-month high of $171.37.

Clorox (NYSE:CLX) last released its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.24 by $0.63. The company had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The firm’s quarterly revenue was up 4.5% on a year-over-year basis. During the same period in the prior year, the firm earned $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Research analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be issued a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a yield of 4.1%. The ex-dividend date is Wednesday, October 22nd. Clorox’s dividend payout ratio is 76.07%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.